Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review

Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review

Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2

Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description A detailed description of the company s operations and business divisions. - Corporate strategy Analyst s summarization of the company s business strategy. - SWOT Analysis A detailed analysis of the company s strengths, weakness, opportunities and threats. - Company history Progression of key events associated with the company. - Major products and services A list of major products, services and brands of the company. - Key competitors A list of key competitors to the company. - Key employees A list of the key executives of the company. - Executive biographies A brief summary of the executives employment history. - Key operational heads A list of personnel heading key departments/functions. - Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history. Highlights Qiagen N.V. (Qiagen) is a healthcare company. It provides extensive products and services such as automated solutions, isolation analysis, data interpretation systems, reagents,accessories and labware, and sample and assay technologies to study the molecular information of biological material. Its sample technologies help isolate and process proteins, DNA and RNA from biological samples such as blood or tissue; and assay technologies facilitate the development of isolated biomolecules such as the DNA of a specific virus for later analysis. The company has over 500 products that include consumable products, automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification, besides open and target specific assays. Qiagen also supplies diagnostic test kits and assays for human and veterinary molecular diagnostics. The company caters to animal pathogens and genotyping, cancer research, drug development, environmental water testing, human identity & forensic testing, microbiology research, among other areas. The company operates in more than 100 countries and sells its products to pharmaceutical and biotechnology 3

companies and research institutions. Qiagen is headquartered in Venlo, the Netherlands. The company intends to enter into Next Generation Sequencing market. To this end, it is developing nextgeneration benchtop sequencer with its subsidiary, Intelligent Bio-Systems, Inc. Qiagen N.V. Key Recent Developments Oct 28, 2015: Qiagen Reports Results For Third Quarter And First Nine Months Of 2015 Oct 05, 2015: QIAGEN launches new bioinformatics solution for hereditary diseases Aug 19, 2015: UC Davis Scientists Spot Mutations in Circulating Tumor DNA with Ingenuity Variant Analysis Jul 29, 2015: QIAGEN reports results for second quarter and first half of 2015 Jun 10, 2015: New Approach on HIV Viral Load Testing Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Note: Some sections may be missing if data is unavailable for the company 4

Additional Details Publisher : Global Data Reference : GDME2456FSA Number of Pages : 74 Report Format : PDF Publisher Information : 5

Table Of Contents for Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review Table of Contents Table of Contents 2List of Tables 4List of Figures 5Section 1 - About the Company 6Qiagen N.V. - Key Facts 6Qiagen N.V. - Key Employees 7Qiagen N.V. - Key Employee Biographies 8Qiagen N.V. - Major Products and Services 9Qiagen N.V. - Medical Equipment Pipeline Products Data 11Qiagen N.V. Pipeline Products by Equipment Type 11Qiagen N.V. Pipeline Products by Development Stage 16Qiagen N.V. - History 20Qiagen N.V. - Company Statement 28Qiagen N.V. - Locations And Subsidiaries 29Head Office 29Other Locations & Subsidiaries 29Qiagen N.V. - Key Manufacturing Facilities 31Joint Venture 31Section 2 Company Analysis 32Qiagen N.V. - Business Description 32Qiagen N.V. - Corporate Strategy 34Qiagen N.V. - SWOT Analysis 35SWOT Analysis - Overview 35Qiagen N.V. - Strengths 35Strength - Established Presence in Molecular Diagnostics Market 35Strength - Success in International Markets 35Strength - Strong Research and Development Activities 35Strength - Improving Financial Position 35Qiagen N.V. - Weaknesses 36Weakness - Substantial Debt 36Weakness - Patent Infringement Concerns 36Qiagen N.V. - Opportunities 37Opportunity - Global In-Vitro Diagnostics Market 37Opportunity - Growth in E7 markets 37Opportunity - Expansion through Acquisitions 37Qiagen N.V. - Threats 38Threat - Intense Competition 38Threat - Stringent Government Regulations 38Threat - Integration of Acquisitions 38Qiagen N.V. - Key Competitors 39Section 3 Company Financial Ratios 40Financial Ratios - Capital Market Ratios 40Financial Ratios - Annual Ratios 41Performance Chart 43Financial Performance 43Financial Ratios - Interim Ratios 44Financial Ratios - Ratio Charts 45Section 4 Company s Lifesciences Financial Deals and Alliances 46Qiagen N.V., Medical Equipment, Deals By Year, 2009 to YTD 2015 46Qiagen N.V., Medical Equipment, Deals By Type, 2009 to YTD 2015 47Qiagen N.V., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 48Qiagen N.V., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 49Qiagen N.V., Recent Deals Summary 50Section 5 Company s Recent Developments 51Oct 28, 2015: Qiagen Reports Results For Third Quarter And First Nine Months Of 2015 51Oct 05, 2015: QIAGEN launches new bioinformatics solution for hereditary diseases 56Aug 19, 2015: UC Davis Scientists Spot Mutations in Circulating Tumor DNA with Ingenuity Variant Analysis 57Jul 29, 2015: QIAGEN reports results for second quarter and first half of 2015 58Jul 13, 2015: FDA Approves Qiagen s Therascreen EGFR Test For Use With Iressa 63Jul 08, 2015: QIAGEN Expands QIAsymphony Test Menu in Partnership with Seegene 64Jun 10, 2015: New Approach on HIV Viral Load Testing 65Jun 08, 2015: QIAGEN and Inova Translational Medicine Institute Introduce New Database of Ethnically and Phenotypically Diverse Whole Genome Information 66May 26, 2015: QIAGEN Launches Clinical Bioinformatics Platform for Next- Generation Sequencing 68May 19, 2015: QIAGEN opens new office in Kuala Lumpur as business expands in Malaysia 69Section 6 Appendix 70Methodology 70Ratio Definitions 70About GlobalData 74Contact Us 74Disclaimer 74 6

List Of Tables in Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review List of Tables Qiagen N.V., Key Facts 6 Qiagen N.V., Key Employees 7 Qiagen N.V., Key Employee Biographies 8 Qiagen N.V., Major Products and Services 9 Qiagen N.V. Number of Pipeline Products by Equipment Type 11 Qiagen N.V. Pipeline Products by Equipment Type 12 Qiagen N.V. Number of Pipeline Products by Development Stage 16 Qiagen N.V. Pipeline Products by Development Stage 17 Qiagen N.V., History 20 Qiagen N.V., Subsidiaries 29 Qiagen N.V., Key Manufacturing Facilities 31 Qiagen N.V., Joint Venture 31 Qiagen N.V., Key Competitors 39 Qiagen N.V., Ratios based on current share price 40 Qiagen N.V., Annual Ratios 41 Qiagen N.V., Interim Ratios 44 Qiagen N.V., Medical Equipment, Deals By Year, 2009 to YTD 2015 46 Qiagen N.V., Medical Equipment, Deals By Type, 2009 to YTD 2015 47 Qiagen N.V., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 48 Qiagen N.V., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015 49 Qiagen N.V., Recent Deals Summary 50 Currency Codes 70 Capital Market Ratios 70 Equity Ratios 71 Profitability Ratios 71 Cost Ratios 72 Liquidity Ratios 72 7

Leverage Ratios 73 Efficiency Ratios 73 8

List Of Figures, Charts and Diagrams in Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review List of Figures Qiagen N.V. Pipeline Products by Equipment Type 11 Qiagen N.V. Pipeline Products by Development Stage 16 Qiagen N.V., Performance Chart (2010-2014) 43 Qiagen N.V., Ratio Charts 45 Qiagen N.V., Medical Equipment, Deals By Year, 2009 to YTD 2015 46 Qiagen N.V., Medical Equipment, Deals by Type, 2009 to YTD 2015 47 Qiagen N.V., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015 48 Qiagen N.V., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015 49 9

How to Buy... Qiagen N.V. (QIA) - Financial and Strategic SWOT Analysis Review Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $125 Single User Price $250 Site License Price $375 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 10